Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.58 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.58 |
| ▸ | ELANE | P08246 | 5/20 | 0.38 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA7 | P43166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21055687 | 1.00 | CYP1A1 (0.58) | CYP1A1CYP1B1ELANEIMPDH2BACE1 | |
| SCHEMBL30849922 | 1.00 | CYP1A1 (0.58) | CYP1A1CYP1B1ELANEIMPDH2BACE1 | |
| Cymopol SCHEMBL21055681 | 0.77 | BACE1 (0.52) | BACE1OSBPPTPN1 | |
| Cymopol SCHEMBL29378158 | 0.77 | BACE1 (0.52) | BACE1OSBPPTPN1 | |
| Cymopol SCHEMBL8649278 | 0.77 | BACE1 (0.52) | BACE1OSBPPTPN1 | |
| SCHEMBL23169734 | 0.76 | CYP1A1 (0.40) | CYP1A1CYP1B1ELANEBACE1MEN1 | |
| SCHEMBL23169668 | 0.74 | ELANE (0.41) | CYP1A1CYP1B1ELANEMEN1KMT2A | |
| SCHEMBL29405262 | 0.74 | CYP1A1 (1.00) | CYP1A1CYP1B1ELANEBACE1MEN1 | |
| SCHEMBL10600948 | 0.67 | CYP1A1 (0.37) | CYP1A1CYP1B1ELANEPTPN1 | |
| SCHEMBL10600941 | 0.67 | CYP1A1 (0.37) | CYP1A1CYP1B1ELANEPTPN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | claimed |
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-04-25 | — | — | US | claimed |
| US-20210161980-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-03 | — | — | US | claimed |
| WO-2019113383-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (US) | 2019-06-13 | — | — | WO | claimed |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-07-11 | — | — | US | disclosed |
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2024-04-25 | — | — | US | disclosed |
| US-20210161980-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-03 | — | — | US | disclosed |
| US-20210161980-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2021-06-03 | — | — | US | disclosed |
| WO-2019113383-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (US) | 2019-06-13 | — | — | WO | disclosed |
| WO-2019113383-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION INCORPORATED (US) | 2019-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240131097-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | CYP1A1 3281/4885CYP1B1 3403/4885ELANE 1102/4885 |
| US-20210161980-A1 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | CYP1A1 3281/4885CYP1B1 3403/4885ELANE 1102/4885 |
| US-20240226211-A9 | SEAWEED EXTRACTS, ISOLATED COMPOUNDS, AND METHODS OF TREATMENT | KEAP1, NFE2L2, TFEB | CYP1A1 3281/4885CYP1B1 3403/4885ELANE 1102/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.